These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14602188)

  • 1. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2003 Nov; 56(3):439-43. PubMed ID: 14602188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits.
    Shin SC; Choi JS
    Int J Pharm; 2002 Mar; 234(1-2):67-73. PubMed ID: 11839438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
    Cho CW; Shin SC
    Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
    Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
    Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits.
    Shin SC; Bum JP; Choi JS
    Int J Pharm; 2000 Nov; 209(1-2):37-43. PubMed ID: 11084244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
    Krishnaiah YS; Bhaskar P; Satyanarayana V
    Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of matrix-membrane transdermal drug delivery system for atenolol.
    Gupta SP; Jain SK
    Drug Deliv; 2004; 11(5):281-6. PubMed ID: 15742552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
    Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
    Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.
    Rao PR; Reddy MN; Ramakrishna S; Diwan PV
    Eur J Pharm Biopharm; 2003 Jul; 56(1):81-5. PubMed ID: 12837485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
    Weon Cho C; Chul Shin S
    Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
    Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
    Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix.
    Cho CW; Kim DB; Cho HW; Shin SC
    Indian J Pharm Sci; 2012 Mar; 74(2):127-32. PubMed ID: 23325993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of atenolol.
    Vergin H; Nitsche V
    J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.